HAEMONETICS CORP/MASS (HAE) Stock Price & Overview
NYSE:HAE • US4050241003
Current stock price
The current stock price of HAE is 60.935 USD. Today HAE is up by 1.2%. In the past month the price increased by 2.99%. In the past year, price decreased by -3.68%.
HAE Key Statistics
- Market Cap
- 2.832B
- P/E
- 12.39
- Fwd P/E
- 11.50
- EPS (TTM)
- 4.92
- Dividend Yield
- N/A
HAE Stock Performance
HAE Stock Chart
HAE Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to HAE. When comparing the yearly performance of all stocks, HAE is a bad performer in the overall market: 78.89% of all stocks are doing better.
HAE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to HAE. While HAE has a great profitability rating, there are some minor concerns on its financial health.
HAE Earnings
On February 5, 2026 HAE reported an EPS of 1.31 and a revenue of 338.97M. The company beat EPS expectations (3.75% surprise) and beat revenue expectations (1.21% surprise).
HAE Forecast & Estimates
15 analysts have analysed HAE and the average price target is 88.64 USD. This implies a price increase of 45.46% is expected in the next year compared to the current price of 60.935.
For the next year, analysts expect an EPS growth of 9.31% and a revenue growth -2.55% for HAE
HAE Groups
Sector & Classification
HAE Financial Highlights
Over the last trailing twelve months HAE reported a non-GAAP Earnings per Share(EPS) of 4.92. The EPS increased by 16.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.31% | ||
| ROA | 7.04% | ||
| ROE | 19.25% | ||
| Debt/Equity | 1.01 |
HAE Ownership
HAE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 31.46 | 62.413B | ||
| ALGN | ALIGN TECHNOLOGY INC | 16.98 | 13.98B | ||
| COO | COOPER COS INC/THE | 13.27 | 13.131B | ||
| SOLV | SOLVENTUM CORP | 10.54 | 11.96B | ||
| LNTH | LANTHEUS HOLDINGS INC | 15.51 | 5.3B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 16.86 | 4.048B | ||
| ICUI | ICU MEDICAL INC | 15.48 | 3.202B | ||
| XRAY | DENTSPLY SIRONA INC | 8.35 | 2.459B | ||
| NEOG | NEOGEN CORP | 27.79 | 2.05B | ||
| UFPT | UFP TECHNOLOGIES INC | 20.07 | 1.532B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.234B | ||
| AVNS | AVANOS MEDICAL INC | 24.13 | 1.146B |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About HAE
Company Profile
The company is headquartered in Boston, Massachusetts and currently employs 3,023 full-time employees.
Company Info
IPO: 1979-10-17
HAEMONETICS CORP/MASS
125 Summer Street
Boston MASSACHUSETTS 02110 US
CEO: Christopher A. Simon
Employees: 3023
Phone: 17818487100
HAEMONETICS CORP/MASS / HAE FAQ
What does HAEMONETICS CORP/MASS do?
The company is headquartered in Boston, Massachusetts and currently employs 3,023 full-time employees.
What is the stock price of HAEMONETICS CORP/MASS today?
The current stock price of HAE is 60.935 USD. The price increased by 1.2% in the last trading session.
What is the dividend status of HAEMONETICS CORP/MASS?
HAE does not pay a dividend.
What is the ChartMill rating of HAEMONETICS CORP/MASS stock?
HAE has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What do analysts say about HAEMONETICS CORP/MASS (HAE) stock?
15 analysts have analysed HAE and the average price target is 88.64 USD. This implies a price increase of 45.46% is expected in the next year compared to the current price of 60.935.
Is HAEMONETICS CORP/MASS (HAE) expected to grow?
The Revenue of HAEMONETICS CORP/MASS (HAE) is expected to decline by -2.55% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the market cap for HAEMONETICS CORP/MASS?
HAEMONETICS CORP/MASS (HAE) has a market capitalization of 2.83B USD. This makes HAE a Mid Cap stock.